Global Tuberculosis Diagnosis and Treatment Market 2022-2028

Description

List of Tables

Global Tuberculosis Diagnosis and Treatment Market Size, Share & Trends Analysis Report, By Diagnosis (Culture based diagnostics, sputum smear microscopy, rapid molecular diagnostics and Other Tests), By Drugs (First Line Drugs and Second Line Drugs), By End-User (Hospitals & Clinics, Government & Non-Government Organizations, and Others), and Forecast 2021-2028

The global tuberculosis diagnosis and treatmentmarket is anticipated to grow at a substantial CAGR of 6.1% during the forecast period. The increasing technological advancement in TB leads to considerable growth in the market. Due to the various technological advancement, new diagnostics solutions are made available to diagnose these diseases which also provides accuracy and speed.The WHO-recommended molecular diagnostic tests are LPAs and Xpert MTB/RIF and the initial diagnosis of TB is made by rapid moleculartests (e.g.Xpert MTB/RIF) and not by conventional microscopy methods. Light-emittingdiode fluorescence microscopy is the recommended method for microscopy at all levelsof laboratory.some of these WHO-endorsed tests can detect mycobacterial gene mutations associated with anti-TB drug resistance, allowing clinicians to tailor effective TB treatment and directly boosting the market. For instance in 2022, WHO announced a new class of tests to diagnose TB infection named Tuberculosis antigen-based skin tests (TBST).These tests represent an alternative to tuberculin skin test (TST) and Interferon-Gamma Release Assays (IGRAs).

The global tuberculosis diagnosis and treatment market is segmented based on technology, products, application and end-user. Based on technology the market is sub-divided into cell-based, and bead-based. Based on products the market is bifurcated into reagents and consumables, components, platforms, services, software, and accessories. Based on application the market is sub-segmented into research and clinical application, and diagnostic application. Based on end-user, the market is sub-segmented into hospitals, research institutes, clinical testing labs, and others. The hospital segment is anticipated to grow at the fastest rate, as hospitals assist the patients to take medical assistance under the observation of experienced surgeons.The increasing number of cancer patients along with growing awareness regarding the various benefits and facilities provided in hospitals is considered a prime factor that is supporting the growth of the hospital segment.

Geographically market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.NorthAmerica dominates the market and is expected to continue its presence over the forecast period. The growth can be attributed to the different factorssuch as different initiatives by governments and non-profit organizations. Accordingto UNDPby 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases.So this will boost the market for the diagnostic market.

The major companies serving the global tuberculosis diagnosis and treatmentmarket are Cepheid Inc., Eiken Chemical Co. Ltd., Hain Lifescience GmbHand others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in 2021 Hain Lifescience GmbH innovated a direct test for the advanced TB laboratory named FluoroTypes based on the innovative FluoroType technology enabling the direct detection of M. tuberculosis complex from direct sample material such as decontaminated pulmonary and, depending on the test, extrapulmonary patient samples

Research Methodology

The market study of the global tuberculosis diagnosis and treatmentmarket is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.
Whitepapers, researchpapers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Tuberculosis diagnosis and treatmentMarket Research and Analysis by Diagnosis

2. Global Tuberculosis diagnosis and treatmentMarket Research and Analysis by Drugs

3. Global Tuberculosis diagnosis and treatmentMarket Research and Analysis by End User

The Report Covers

Comprehensive research methodology of the globaltuberculosis diagnosis and treatmentmarket.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global tuberculosis diagnosis and treatmentmarket.
Insights about market determinants that are stimulating the global tuberculosis diagnosis and treatmentmarket.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2017186

Category-Pharmaceuticals

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the GlobalTuberculosis diagnosis and treatmentMarket
Recovery Scenario of GlobalTuberculosis diagnosis and treatmentMarket
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. BY Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key CompanyAnalysis
- 3.1.1. Otsuka Pharmaceuticals Co. Ltd.
  - 3.1.1.1. Overview
  - 3.1.1.2. Financial Analysis
  - 3.1.1.3. SWOT Analysis
  - 3.1.1.4. Recent Developments
- 3.1.2. Johnson & Johnson Services Inc.
  - 3.1.2.1. Overview
  - 3.1.2.2. Financial Analysis
  - 3.1.2.3. SWOT Analysis
  - 3.1.2.4. Recent Developments
- 3.1.3. Abbott Laboratories, Inc.
  - 3.1.3.1. Overview
  - 3.1.3.2. Financial Analysis
  - 3.1.3.3. SWOT Analysis
  - 3.1.3.4. Recent Developments
- 3.1.4. Becton, Dickinson and Co.
  - 3.1.4.1. Overview
  - 3.1.4.2. Financial Analysis
  - 3.1.4.3. SWOT Analysis
  - 3.1.4.4. Recent Developments
- 3.1.5. Thermo Fisher Scientific, Inc.
  - 3.1.5.1. Overview
  - 3.1.5.2. Financial Analysis
  - 3.1.5.3. SWOT Analysis
  - 3.1.5.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players

4. Market Segmentation

4.1. GlobalTuberculosis diagnosis and treatmentMarket, by Diagnosis
- 4.1.1. Laboratory Testing
- 4.1.2. Nucleic Acid Tests
- 4.1.3. Radiography
- 4.1.4. Drug Susceptibility Test
- 4.1.5. Other Tests
4.2. Global Tuberculosis diagnosis and treatmentMarket, by Drugs
- 4.2.1. First Line Drugs
- 4.2.2. Second Line Drugs
4.3. Global Tuberculosis diagnosis and treatment Market, by End-user
- 4.3.1. Hospitals& Clinics
- 4.3.2. Government & Non-Government Organizations
- 4.3.3. Others

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. Abbott Laboratories Inc.
6.2. Akonni Biosystems, Inc.
6.3. Becton Dickinson and Co.
6.4. Biochemical and Synthetic Products Pvt Ltd
6.5. Biomerieux SA
6.6. Cepheid Inc.
6.7. Eiken Chemical Co. Ltd.
6.8. EpistemLtd.
6.9. F. Hoffmann-LA Roche AG
6.10. GlaxoSmithKline PLC
6.11. Hain Lifescience GmbH
6.12. HologicInc.
6.13. Johnson & Johnson Services, Inc.
6.14. LabatecPharma SA
6.15. Lupin Pharmaceuticals Inc.
6.16. Novartis AG
6.17. Otsuka Pharmaceutical Co. Ltd.
6.18. PerkinElmer Inc.
6.19. QiagenGmbH
6.20. Sanofi SA
6.21. Thermo Fisher Scientific, Inc.